2024-09-03 - Analysis Report
##  MRK Stock Analysis Report

**Company Overview:** 
MRK, known as Merck & Co., Inc., is a global healthcare company that develops, manufactures, and markets a broad range of prescription medicines, vaccines, and animal health products.

**Performance Analysis:**

**1.  Performance vs. S&P 500:**

*   MRK's cumulative return is 52.93%, lagging behind the S&P 500 (VOO) which has a cumulative return of 89.66%. 
*   This indicates that MRK has underperformed compared to the broader market, with a relative underperformance of 38.25% based on historical data.

**2.  Recent Price Movement:**

*   Closing price: $118.45
*   5-day moving average: $117.22
*   20-day moving average: $114.88
*   60-day moving average: $122.73

MRK's recent price movement shows a short-term upward trend, as the closing price is above both the 5-day and 20-day moving average. However, the 60-day moving average is higher, suggesting potential for a longer-term correction.

**3.  Technical Indicators:**

*   RSI (Relative Strength Index): 81.9 - This indicates the stock is currently in overbought territory, implying potential for a short-term correction.
*   PPO (Percentage Price Oscillator): 0.74 - The positive value indicates a bullish signal, but the high RSI suggests the current momentum might be unsustainable.
*   Delta_Previous_Relative_Divergence: -6.71 - This indicates a recent short-term downward trend in the relative strength of MRK compared to the market.
*   Expected_Return: 11.87% - This indicates a potential 5-year expected return based on current investment levels.

**4.  Recent Earnings and Outlook:**

| Date        | EPS      | Revenue   |
|-------------|----------|-----------|
| 2024-08-05 | 2.15    | 16.11 B$ |
| 2024-05-03 | 1.88    | 15.78 B$ |
| 2023-11-03 | 1.87    | 15.96 B$ |
| 2023-08-07 | -2.35   | 15.04 B$ |
| 2024-08-05 | -2.35   | 15.04 B$ |

MRK's recent earnings have been consistently strong, with the latest quarter showing an EPS of 2.15 and revenue of 16.11 billion dollars. This exceeds expectations, showcasing continued positive financial performance. 

**Overall Analysis:**

MRK has shown strong recent earnings performance and a bullish technical signal, suggesting potential for future growth. However, the stock is currently overbought and has underperformed the broader market in the past. 

Investors should consider the high RSI and the potential for a short-term correction due to overbought conditions. Despite this, MRK's strong financial performance and positive outlook provide a promising long-term investment opportunity. 
